Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Phase 1 study of CB-839, a first-in-class, glutaminase inhibitor in patients with multiple myeloma and lymphoma
Anticancer Res (2004) 24:2783840
The best nutrients come from eating a well-balanced diet, as recommended by a licensed dietitian
The study conditions were as follows: temperature of 40 C, relative humidity of 75%, continuous exposure for 28 days, peptides stored in original, hermetically sealed glass vials
Mechanical cyclic strain induces ceramide generation in endothelial cells
Would definitely recommend to anyone looking for this type of treatment
US$ 27.51
US$ 29.94
US$ 21.78
US$ 22.34
US$ 22.93
US$ 29.25
